Schedule 13G/A: William Scully Discloses Near-10% Stake in Prothena
Rhea-AI Filing Summary
William P. Scully reports beneficial ownership of 5,351,846 ordinary shares of Prothena Corporation plc, representing approximately 9.94% of the issuer's outstanding shares based on the issuer's reported figure of 53,826,982 shares. The holdings combine direct ownership and interests across investment vehicles, including a direct stake, an LLC, multiple IRAs, trusts and grantor retained annuity trusts.
The filing breaks ownership into 768,000 shares over which Mr. Scully has sole voting and dispositive power and 4,583,846 shares over which he has shared voting and dispositive power, reflecting a mix of individually held shares and positions held through managed or trust arrangements.
Positive
- Material stake disclosed: Aggregate beneficial ownership of 5,351,846 shares (~9.94%) is clearly reported.
- Clear breakdown of control: Filing specifies 768,000 shares with sole voting/dispositive power and 4,583,846 with shared power, improving transparency.
Negative
- None.
Insights
TL;DR: A near-10% stake is material; it signals a significant investor position without an asserted intent to change control.
The filing discloses an aggregate position of 5,351,846 shares (≈9.94%), split between sole and shared voting/dispositive powers. For investors, a holder approaching 10% can be important for shareholder dynamics, potential engagement, and voting outcomes. The certification that the position was not acquired to influence control implies passive or investment-oriented intent, but the size alone makes this an item of interest for governance and possible future disclosures.
TL;DR: The combination of sole and shared control across trusts and funds creates governance complexity despite an asserted non-control intent.
The record shows 768,000 shares with sole power and 4,583,846 shares with shared power due to trusts, IRAs and managed accounts. Shared dispositive or voting power through trust features and substitution rights can complicate clear attribution of influence. Stake concentration near 10% warrants monitoring of any future amendments or coordinated actions that could change governance dynamics.
FAQ
How many Prothena (PRTA) shares does William P. Scully beneficially own?
What percentage of Prothena does Scully's stake represent?
How is Scully's voting and dispositive power divided?
Through which vehicles are the shares held?
Does the filing state intent to influence control of Prothena?